Literature DB >> 17200197

Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.

Arno Hänninen1, Rita Nurmela, Mikael Maksimow, Jarkko Heino, Sirpa Jalkanen, Christian Kurts.   

Abstract

Organ infiltration by T cells depends on the adhesion molecules expressed in these sites and on homing receptors expressed by the T cells. Here, we have studied which form of priming can enable T cells to home to pancreatic islets. To this end, we have used transgenic mice expressing the model autoantigen ovalbumin in pancreatic islets and transgenic ovalbumin-specific CD4 and CD8 T cells. We demonstrate that these T cells were imprinted with homing receptor patterns characteristic for the site of priming, such as alpha4beta7 integrin for mucosal antigen delivery or functionally active alpha4beta1 integrin for islet autoantigens. The adhesion molecules corresponding to these receptors were found to be constitutively expressed in islets, enabling T cells bearing these receptors to infiltrate the islets and to cause diabetes. Disease was prevented only by blockade of the endothelial adhesion molecule, ligand of homing receptors with which the T cells were imprinted. Thus, different priming locations induced different homing mechanisms, allowing T cells to target the islets. This may contribute to the susceptibility of islets to T-cell-mediated attack. Furthermore, it may pertain to the design of adhesion-modulating therapies alone or in combination with external autoantigen administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200197      PMCID: PMC1762684          DOI: 10.2353/ajpath.2007.060142

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Immunotherapy of insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Curr Opin Immunol       Date:  2001-10       Impact factor: 7.486

2.  Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

Authors:  Kevan C Herold; William Hagopian; Julie A Auger; Ena Poumian-Ruiz; Lesley Taylor; David Donaldson; Stephen E Gitelman; David M Harlan; Danlin Xu; Robert A Zivin; Jeffrey A Bluestone
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  The shaping of the T cell repertoire.

Authors:  M Correia-Neves; C Waltzinger; D Mathis; C Benoist
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

4.  Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

Authors:  C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

Review 5.  Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens.

Authors:  J F Miller; C Kurts; J Allison; H Kosaka; F Carbone; W R Heath
Journal:  Immunol Rev       Date:  1998-10       Impact factor: 12.988

6.  Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody.

Authors:  L Weiss; S Slavin; S Reich; P Cohen; S Shuster; R Stern; E Kaganovsky; E Okon; A M Rubinstein; D Naor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Retinoic acid imprints gut-homing specificity on T cells.

Authors:  Makoto Iwata; Asami Hirakiyama; Yuko Eshima; Hiroyuki Kagechika; Chieko Kato; Si-Young Song
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Extraislet infiltration in NOD mouse pancreas: observations after immunomodulation.

Authors:  G Papaccio; G Chieffi-Baccari; V Mezzogiorno; V Esposito
Journal:  Pancreas       Date:  1993-07       Impact factor: 3.327

9.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.

Authors:  A Hamann; D Jablonski-Westrich; A Duijvestijn; E C Butcher; H Baisch; R Harder; H G Thiele
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

10.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  26 in total

1.  Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.

Authors:  Chiara Sorini; Marika Falcone
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

2.  Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.

Authors:  M Hedman; M Faresjö; S Axelsson; J Ludvigsson; R Casas
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 3.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

Review 4.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 5.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

6.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 7.  Gut microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 8.  Type 1 diabetes and gut microbiota: Friend or foe?

Authors:  Changyun Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2015-03-05       Impact factor: 7.658

9.  Detection of enteroviruses in the intestine of type 1 diabetic patients.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; S Oikarinen; K Vuori; K Kaukinen; I Rantala; M Mäki; H Hyöty
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

10.  Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Authors:  Mikael Maksimow; Catharina Alam; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2008-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.